Log in
EPA:SAN

Sanofi Stock Forecast, Price & News

€88.44
+0.41 (+0.47 %)
(As of 09/18/2020 12:00 AM ET)
Add
Compare
Today's Range
€88.21
Now: €88.44
€89.40
50-Day Range
€83.57
MA: €86.73
€90.26
52-Week Range
€63.09
Now: €88.44
€92.97
Volume5.62 million shs
Average Volume3.05 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Sanofi provides therapeutic solutions. It offers Cerezyme and Cerdelga for Gaucher disease, Myozyme and Lumizyme for Pompe disease, Fabrazyme for Fabry disease, and Aldurazyme for mucopolysaccharidosis Type 1; Aubagio, an immunomodulatory; and Lemtrada, a monoclonal antibody to treat multiple sclerosis. The company also provides Jevtana, a taxane derivative for prostate cancer; Taxotere, a taxoid for cancers; Eloxatin, an agent for colorectal cancer; Thymoglobulin, an immunosuppressive and immunomodulating agent; Mozobil, a hematopoietic stem cell mobilizer; and Zaltrap, a protein for metastatic colorectal cancer. In addition, it offers Dupixent for atopic dermatitis; Kevzara for rheumatoid arthritis; Lantus, Toujeo, Apidra, and Insuman insulins; Amaryl, an oral sulfonylurea; Lyxumia/Adlyxin, a GLP-1 receptor agonist; Soliqua 100/33/Suliqua, an insulin glargine and lixisenatide combination to treat diabetes; Admelog/Insulin lispro insulin; Praluent, a cholesterol-lowering drug; and Multaq, an anti-arrhythmic drug for atrial fibrillation. Further, the company provides Plavix, an anti-platelet agent for atherothrombotic conditions; Lovenox, a heparin for the prophylaxis and venous thromboembolism and acute coronary syndrome; Aprovel and CoAprovel anti-hypertensives; Renagel and Renvela oral phosphate binders for patients undergoing dialysis; Synvisc and Synvisc-One viscosupplements for osteoarthritis; Stilnox for insomnia; and Allegra for seasonal allergic rhinitis and uncomplicated hives. Additionally, it offers consumer health care products and generic medicines; and pediatric, influenza, adult and adolescent booster, meningitis, and travel and endemic vaccines. Sanofi has strategic alliance with Sensile Medical Ltd.; collaboration with Evotec AG; and partnership with REVOLUTION Medicines, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Read More
Sanofi logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.16 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+33-1-53774000

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableOptionable
€88.44
+0.41 (+0.47 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SAN News and Ratings via Email

Sign-up to receive the latest news and ratings for SAN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Sanofi (EPA:SAN) Frequently Asked Questions

How has Sanofi's stock price been impacted by Coronavirus?

Sanofi's stock was trading at €79.63 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SAN shares have increased by 11.1% and is now trading at €88.44.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Sanofi?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sanofi in the last year. There are currently 2 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Sanofi
.

What price target have analysts set for SAN?

12 analysts have issued twelve-month price objectives for Sanofi's stock. Their forecasts range from €85.00 to €110.00. On average, they anticipate Sanofi's stock price to reach €101.42 in the next year. This suggests a possible upside of 14.7% from the stock's current price.
View analysts' price targets for Sanofi
.

Who are some of Sanofi's key competitors?

What other stocks do shareholders of Sanofi own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sanofi investors own include Skechers USA (SKX), Sanofi (SNY), NVIDIA (NVDA), salesforce.com (CRM), Intel (INTC), Bank of America (BAC), Encana (ECA), Tronox (TROX), Tesla (TSLA) and Advanced Micro Devices (AMD).

Who are Sanofi's key executives?

Sanofi's management team includes the following people:
  • Mr. Olivier Brandicourt, CEO & Director (Age 63)
  • Mr. Jean-Baptiste Chasseloup de Chatillon, Exec. VP & CFO (Age 54)
  • Mr. Laurent Gilhodes, Principal Accounting Officer and VP of Corp. Accounting
  • Mr. Bruno Ménard, Chief Information officer
  • Mr. George Grofik, Head of Investor Relations

What is Sanofi's stock symbol?

Sanofi trades on the EPA under the ticker symbol "SAN."

What is Sanofi's stock price today?

One share of SAN stock can currently be purchased for approximately €88.44.

What is Sanofi's official website?

The official website for Sanofi is en.sanofi.com.

How can I contact Sanofi?

Sanofi's mailing address is 54 rue la Boetie, PARIS, 75008, France. The company can be reached via phone at +33-1-53774000.

This page was last updated on 9/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.